Determinants of platelet catecholamine content: uptake and retention of catecholamines by human platelets in vitro
- PMID: 21043939
- DOI: 10.3109/09537109009005469
Determinants of platelet catecholamine content: uptake and retention of catecholamines by human platelets in vitro
Abstract
The utility of platelet catecholamine determination in assessing sympathetic nervous system activity depends on the extent to which transient fluctuations of plasma catecholamine concentration can affect platelet catecholamine content. In order to quantitate the relationship between plasma and platelet catecholamine content, the concentrations of norepinephrine, epinephrine and dopamine needed to produce an increase in platelet catecholamines in vitro were determined. The threshold for epinephrine accumulation was 10(-9)M while the thresholds for norepinephrine and dopamine were an order of magnitude higher. The uptake of catecholamines was also found to differ with regard to the time course and the amount of catecholamine accumulated. For example, after 2 h in the presence of equimolar (2 × 10(-8)M) concentrations of catecholamine the platelet content of norepinephrine doubled and epinephrine rose 10-fold and dopamine 20-fold. When platelets that had been loaded with catecholamines were suspended in catecholamine-free buffer, significant amounts of catecholamines were still retained in the platelets after 3 h, but retention of norepinephrine was greater than that of epinephrine. These results indicate the importance of the concentration of the particular catecholamine, duration of exposure of platelets to the catecholamine and the ability of platelets to retain catecholamines, in determining the relationship between plasma and platelet catecholamine content.
Similar articles
-
Distribution of free and conjugated catecholamines between plasma, platelets and erythrocytes: different effects of intravenous and oral catecholamine administrations.J Pharmacol Exp Ther. 1991 Apr;257(1):232-8. J Pharmacol Exp Ther. 1991. PMID: 2019988
-
Decreased platelet-free dopamine and unchanged noradrenaline and adrenaline in essential hypertension.Thromb Haemost. 1988 Oct 31;60(2):251-4. Thromb Haemost. 1988. PMID: 3217920
-
Catecholamine sulfates and platelet phenolsulfotransferase activity in essential hypertension.J Lab Clin Med. 1984 Aug;104(2):238-44. J Lab Clin Med. 1984. PMID: 6589333
-
Renal catecholamine metabolism.Miner Electrolyte Metab. 1989;15(1-2):16-23. Miner Electrolyte Metab. 1989. PMID: 2644519 Review.
-
Role of catecholamines in platelet function: pathophysiological and clinical significance.Eur J Clin Invest. 1996 May;26(5):353-70. doi: 10.1046/j.1365-2362.1996.150293.x. Eur J Clin Invest. 1996. PMID: 8796362 Review.
Cited by
-
Beyond the heart: a review exploring non-cardiovascular effects of vasoactive agents.Front Pharmacol. 2025 Jul 10;16:1533437. doi: 10.3389/fphar.2025.1533437. eCollection 2025. Front Pharmacol. 2025. PMID: 40709092 Free PMC article. Review.
LinkOut - more resources
Full Text Sources